Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study

NCT00497666 · clinicaltrials.gov ↗

UNKNOWN

Status

OTHER_GOV

Sponsor class

Conditions

Diabetes
Diabetic Nephropathy
Renal Protection

Interventions

DRUG: Rosiglitasone (retrospective observation)

Sponsor

Assaf-Harofeh Medical Center